Darío Ponce de León

1.3k total citations
31 papers, 653 citations indexed

About

Darío Ponce de León is a scholar working on Rheumatology, Epidemiology and Hematology. According to data from OpenAlex, Darío Ponce de León has authored 31 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Rheumatology, 12 papers in Epidemiology and 9 papers in Hematology. Recurrent topics in Darío Ponce de León's work include Rheumatoid Arthritis Research and Therapies (17 papers), Autoimmune and Inflammatory Disorders Research (9 papers) and Tuberculosis Research and Epidemiology (8 papers). Darío Ponce de León is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (17 papers), Autoimmune and Inflammatory Disorders Research (9 papers) and Tuberculosis Research and Epidemiology (8 papers). Darío Ponce de León collaborates with scholars based in United States, Brazil and Mexico. Darío Ponce de León's co-authors include Kenneth Kwok, Juan J. Gómez‐Reino, Yoshiya Tanaka, Eric M. Mortensen, Hernán Valdez, Eduardo M. Acevedo‐Vásquez, Ahmet Gül, Myrna Cardiel, Tamara Lukić and Richard J. Riese and has published in prestigious journals such as Gastroenterology, Annals of the Rheumatic Diseases and Anesthesia & Analgesia.

In The Last Decade

Darío Ponce de León

30 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Darío Ponce de León United States	9	328	296	258	247	120	31	653
Alejandro Souto Spain	10	110 0.3×	116 0.4×	98 0.4×	419 1.7×	205 1.7×	11	660
K. Watson United Kingdom	5	109 0.3×	121 0.4×	86 0.3×	399 1.6×	154 1.3×	12	637
J. A. C. Nery Brazil	15	644 2.0×	371 1.3×	347 1.3×	42 0.2×	127 1.1×	26	984
Jeanne Emmons United States	11	325 1.0×	593 2.0×	331 1.3×	63 0.3×	139 1.2×	18	884
Pavol Papay Austria	15	335 1.0×	576 1.9×	323 1.3×	67 0.3×	311 2.6×	37	1.2k
Giammarco Mocci Italy	14	115 0.4×	358 1.2×	135 0.5×	59 0.2×	190 1.6×	38	714
Irena Litinsky Israel	12	92 0.3×	121 0.4×	46 0.2×	372 1.5×	243 2.0×	21	651
Federica Invernizzi Italy	15	143 0.4×	536 1.8×	106 0.4×	45 0.2×	78 0.7×	51	831
Go Kuwata Japan	15	159 0.5×	199 0.7×	304 1.2×	196 0.8×	40 0.3×	32	646
Susie K. Lee United States	7	111 0.3×	497 1.7×	237 0.9×	61 0.2×	150 1.3×	8	765

Countries citing papers authored by Darío Ponce de León

Since Specialization

Citations

This map shows the geographic impact of Darío Ponce de León's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darío Ponce de León with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darío Ponce de León more than expected).

Fields of papers citing papers by Darío Ponce de León

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darío Ponce de León. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darío Ponce de León. The network helps show where Darío Ponce de León may publish in the future.

Co-authorship network of co-authors of Darío Ponce de León

This figure shows the co-authorship network connecting the top 25 collaborators of Darío Ponce de León. A scholar is included among the top collaborators of Darío Ponce de León based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darío Ponce de León. Darío Ponce de León is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Citera, Gustavo, Eduardo Mysler, Adriana María Kakehasi, et al.. (2024). Cardiovascular Events, Malignancies, and Efficacy Outcomes in Latin American Patients With Rheumatoid Arthritis Receiving Tofacitinib or Tumor Necrosis Factor Inhibitors. JCR Journal of Clinical Rheumatology. 30(5). 208–216. 1 indexed citations

Guzmán, Renato, et al.. (2023). Impact of access to treatment on patient‐reported outcomes among rheumatoid arthritis patients with tDMARDs and bDMARDS in two Latin‐American countries: A prospective observational study. Health Science Reports. 6(3). e1034–e1034. 4 indexed citations

Citera, Gustavo, et al.. (2023). Tofacitinib Efficacy in Patients with Rheumatoid Arthritis and Probable Depression/Anxiety: Post Hoc Analysis of Phase 3 and 3b/4 Randomized Controlled Trials. Rheumatology and Therapy. 11(1). 35–50. 2 indexed citations

Schneeberger, Emilce E., Gustavo Citera, Peter Nash, et al.. (2022). Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofacitinib studies. Seminars in Arthritis and Rheumatism. 58. 152134–152134. 7 indexed citations

Schneeberger, Emilce E., et al.. (2022). Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS) Versus ASDAS: A Post Hoc Analysis of a Randomized Controlled Trial. The Journal of Rheumatology. 49(10). 1100–1108. 5 indexed citations

Colombel, Jean‐Frédéric, Péter L. Lakatos, Genoile Oliveira Santana, et al.. (2021). Diagnostic accuracy of patient‐reported outcomes in predicting endoscopic subscore in patients with ulcerative colitis. 3(3). 161–168. 2 indexed citations

Gauthier, Geneviève, et al.. (2021). Treatment patterns and sequencing in patients with rheumatic diseases: a retrospective claims data analysis. Current Medical Research and Opinion. 37(12). 2185–2196. 5 indexed citations

Citera, Gustavo, Rakesh K. Jain, Fedra Irazoque-Palazuelos, et al.. (2020). THU0196 TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INDICATIVE OF DEPRESSION AND/OR ANXIETY: A POST HOC ANALYSIS OF PHASE 3 AND PHASE 3B/4 CLINICAL TRIALS. Annals of the Rheumatic Diseases. 79. 318–319. 3 indexed citations

Rubin, David T., Marla C. Dubinsky, Silvio Danese, et al.. (2020). Tu1866 EFFICACY AND SAFETY OF AN ADDITIONAL 8 WEEKS OF TOFACITINIB INDUCTION THERAPY: UPDATED RESULTS OF THE OCTAVE OPEN STUDY FOR TOFACITINIB 8-WEEK INDUCTION NON-RESPONDERS. Gastroenterology. 158(6). S–1194. 1 indexed citations

10.

Taylor, Peter C., Neil Betteridge, T. Michelle Brown, et al.. (2020). <p>Treatment Mode Preferences in Rheumatoid Arthritis: Moving Toward Shared Decision-Making</p>. Patient Preference and Adherence. Volume 14. 119–131. 15 indexed citations

11.

Kotze, Paulo Gustavo, Flávio Steinwurz, Carlos Fernando de Magalhães Francisconi, et al.. (2020). Review of the epidemiology and burden of ulcerative colitis in Latin America. Therapeutic Advances in Gastroenterology. 13. 3974120603–3974120603. 30 indexed citations

12.

Citera, Gustavo, Emilce E. Schneeberger, Peter Nash, et al.. (2019). Comparison of Different Remission Indices in Patients with Psoriatic Arthritis: A Post Hoc Analysis of Data from Phase 3 Tofacitinib Studies. Queensland's institutional digital repository (The University of Queensland). 26. 1 indexed citations

13.

Radominski, S., Claiton Viegas Brenol, Cristiano A. F. Zerbini, et al.. (2018). Tofacitinib, an oral Janus kinase inhibitor, in patients from Brazil with rheumatoid arthritis. Medicine. 97(31). e11609–e11609. 7 indexed citations

14.

Soriano, Enrique R., Gustavo Citera, Mario H. Cardiel, et al.. (2018). FRI0099 Liver enzyme abnormalities after tofacitinib treatment in patients with hepatic steatosis from the rheumatoid arthritis, psoriatic arthritis and psoriasis clinical programmes. Annals of the Rheumatic Diseases. 77. 593–594. 3 indexed citations

15.

Citera, Gustavo, Eduardo Mysler, Oscar Rillo, et al.. (2017). Safety of Tofacitinib in the Treatment of Rheumatoid Arthritis in Latin America Compared With the Rest of the World Population. JCR Journal of Clinical Rheumatology. 23(4). 193–199. 13 indexed citations

16.

Zerbini, Cristiano A. F., S. Radominski, Mario H. Cardiel, et al.. (2016). Efficacy and Safety of Tofacitinib Monotherapy Versus Combination Therapy in a Latin American Subpopulation of Patients with Rheumatoid Arthritis: A Pooled Phase 3 Analysis. JCR Journal of Clinical Rheumatology. 1 indexed citations

17.

Zerbini, Cristiano A. F., Mario H. Cardiel, Gustavo Citera, et al.. (2016). Herpes zoster in patients with rheumatoid arthritis: pooled analyses of tofacitinib phase 2, 3 and long-term extension studies in a Latin American subpopulation. Universidad de Chile. 1 indexed citations

18.

Winthrop, Kevin, Ahmet Gül, Myrna Cardiel, et al.. (2015). Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 75(6). 1133–1138. 182 indexed citations

19.

Acevedo‐Vásquez, Eduardo M., Darío Ponce de León, & Rocío V. Gamboa‐Cárdenas. (2009). Latent Infection and Tuberculosis Disease in Rheumatoid Arthritis Patients. Rheumatic Disease Clinics of North America. 35(1). 163–181. 13 indexed citations

20.

León, Darío Ponce de, et al.. (2005). Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis. Annals of the Rheumatic Diseases. 64(9). 1360–1361. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact